Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response

1. Agirre, X.
2. Fontalba, A.
3. Andreu, E.J.
4. Odero, M.D.
5. Larráyoz, M.J.
6. Montiel, C.
7. Calasanz, M.J.
8. Fernández-Luna, J.L.
9. Prósper, F.